World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
24626
World Ranking
13756
National Ranking
1278

Tommy B. Andersson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Tommy B. Andersson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 270 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Tommy B. Andersson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Tommy B. Andersson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Tommy B. Andersson is affiliated with AstraZeneca in the United Kingdom. Their research primarily focuses on the intersection of medicine and pharmacology, toxicology, and pharmaceutics, with significant contributions in pharmacology as a subfield. The main topics addressed in their work include pharmacogenetics and drug metabolism, drug transport and resistance mechanisms, diet and metabolism studies, pancreatic function and diabetes, drug-induced hepatotoxicity and protection, liver disease diagnosis and treatment, and pharmacology related to obesity treatment.

Andersson's recent publications span various respected journals. Notable papers include:

  • Primary Human Hepatocyte Spheroid Model as a 3D In Vitro Platform for Metabolism Studies, 2020, Journal of Pharmaceutical Sciences
  • Clinically Relevant Cytochrome P450 3A4 Induction Mechanisms and Drug Screening in Three-Dimensional Spheroid Cultures of Primary Human Hepatocytes, 2020, Clinical Pharmacology & Therapeutics
  • Correlation of Body Weight and Composition With Hepatic Activities of Cytochrome P450 Enzymes, 2020, Journal of Pharmaceutical Sciences
  • Drug Disposition Protein Quantification in Matched Human Jejunum and Liver From Donors With Obesity, 2022, Clinical Pharmacology & Therapeutics
  • Short- and long-term effects of body weight, calorie restriction and gastric bypass on CYP1A2, CYP2C19 and CYP2C9 activity, 2022, British Journal of Clinical Pharmacology

Throughout these publications, Andersson has collaborated frequently with several co-authors, including Rasmus Jansson-Löfmark, Christine Wegler, Ida Robertsen, Hege Christensen, and Jøran Hjelmesæth.

Their work is often published in journals such as the Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics, bioRxiv (Cold Spring Harbor Laboratory), British Journal of Clinical Pharmacology, and Clinical and Translational Science.

Andersson's research has contributed broadly to understanding pharmacogenetics, drug metabolism, and the role of body weight and metabolism in pharmacologic processes and disease mechanisms. Their investigations into cytochrome P450 enzymes and drug disposition proteins reflect an emphasis on how physiological factors influence drug metabolism and therapeutic efficacy.

Best Publications

  • Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): an interim analysis of a randomised controlled trial

    Jörg Ederle;Joanna Dobson;Joanna Dobson;Roland L. Featherstone;Leo H. Bonati;Leo H. Bonati

  • Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities

    Xue-Qing Li;Tommy B. Andersson;Marie Ahlström;Lars Weidolf

  • Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.

    Tommy Andersson

  • Stereoselective Metabolism of Omeprazole by Human Cytochrome P450 Enzymes

    Angela Äbelö;Tommy B. Andersson;Madeleine Antonsson;Anna Knuts Naudot

  • Physiological Disturbances in Fish Living in Coastal Water Polluted with Bleached Kraft Pulp Mill Effluents

    Tommy Andersson;Lars Förlin;Jan Härdig;Åke Larsson

  • Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

    Bruce C V Campbell;Charles B L M Majoie;Gregory W Albers;Bijoy K Menon

  • Evaluation of HepaRG Cells as an In Vitro Model for Human Drug Metabolism Studies

    Kajsa P. Kanebratt;Tommy B. Andersson

  • Esomeprazole provides improved acid control vs. omeprazole In patients with symptoms of gastro-oesophageal reflux disease.

    Lind T;Rydberg L;Kylebäck A;Jonsson A

  • Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis

    Andreas Kindmark;A Jawaid;C G Harbron;B J Barratt

  • Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region.

    Anna Westlind;Lena Löfberg;Niclas Tindberg;Tommy B. Andersson

  • Neutrophil extracellular traps in ischemic stroke thrombi.

    Elodie Laridan;Frederik Denorme;Linda Desender;Olivier François

  • Regulation of the cytochrome P450 enzyme system in fish

    Tommy Andersson;Lars Förlin

  • Amodiaquine clearance and its metabolism to N-desethylamodiaquine is mediated by CYP2C8: a new high affinity and turnover enzyme-specific probe substrate.

    Xue-Qing Li;Anders Björkman;Tommy B. Andersson;Marianne Ridderström

  • Pharmacokinetic Studies with Esomeprazole, the (S)-Isomer of Omeprazole

    Tommy Andersson;Mohammed Hassan-Alin;Göran Hasselgren;Kerstin Röhss

  • Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism.

    Anna Westlind-Johnsson;Sarah Malmebo;Anna Johansson;Charlotta Otter

  • Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.

    Uwe Marx;Tommy B Andersson;Anthony Bahinski;Mario Beilmann

  • Natural History of Dural Arteriovenous Shunts

    Michael Söderman;Ladislav Pavic;Göran Edner;Staffan Holmin

  • Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data.

    Xue-Qing Li;Anders Björkman;Tommy B. Andersson;Lars L. Gustafsson

  • Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43.

    Anna Westlind;Sarah Malmebo;Inger Johansson;Charlotta Otter

  • The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human

    Tommy B Andersson;Kajsa P Kanebratt;John Gerry Kenna

Frequent Co-Authors

Magnus Ingelman-Sundberg
Magnus Ingelman-Sundberg Karolinska Institute
Per Artursson
Per Artursson Uppsala University
Inger Johansson
Inger Johansson Karolinska Institute
Ulf Diczfalusy
Ulf Diczfalusy Karolinska University Hospital
Albert J. Yoo
Albert J. Yoo Harvard University
Tudor G. Jovin
Tudor G. Jovin Cooper University Hospital
Antoni Dávalos
Antoni Dávalos Autonomous University of Barcelona
David S. Liebeskind
David S. Liebeskind University of California, Los Angeles
Krister Kristensson
Krister Kristensson Karolinska Institute
Bruce C.V. Campbell
Bruce C.V. Campbell Royal Melbourne Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering medical studies in the USA, there are several related online degrees and alternative career pathways available. Many students choose to explore fields that support healthcare, sometimes as a stepping-stone to medical school or as rewarding careers in their own right.

For those interested in the administrative side of healthcare, consider a healthcare administration degree. These programs equip you with leadership skills and an understanding of medical systems—often through convenient online options.

If you want to work directly with patient care but are looking for nursing programs with less stringent entry requirements, explore nursing schools that don't require teas or hesi. This can make starting your nursing journey more accessible.

Additionally, allied health paths such as online medical billing and coding with financial aid offer quick entry into healthcare, often without a clinical component.

Finally, for registered nurses looking to advance their careers, an rn to np bridge program provides a streamlined route to become a nurse practitioner, opening up broader practice opportunities and leadership roles.

Best Scientists Citing Tommy B. Andersson

Trending Scientists

Recently Published Articles